Your browser doesn't support javascript.
loading
Noradrenergic cardiac denervation is associated with gait velocity in Parkinson disease: a dual ligand PET study.
Carli, G; Kanel, P; Roytman, S; Pongmala, C; Albin, R L; Raffel, D M; Scott, P J H; Bohnen, N I.
Afiliación
  • Carli G; Department of Neurology, University of Michigan, Ann Arbor, MI, 48109, USA. gcarli@med.umich.edu.
  • Kanel P; Morris K. Udall Center of Excellence for Parkinson's Disease Research, University of Michigan, Ann Arbor, MI, 48109, USA. gcarli@med.umich.edu.
  • Roytman S; Functional Neuroimaging, Cognitive, and Mobility Laboratory, Department of Radiology, University of Michigan, Ann Arbor, MI, USA. gcarli@med.umich.edu.
  • Pongmala C; Morris K. Udall Center of Excellence for Parkinson's Disease Research, University of Michigan, Ann Arbor, MI, 48109, USA.
  • Albin RL; Department of Radiology, University of Michigan, Ann Arbor, MI, 48109, USA.
  • Raffel DM; Parkinson's Foundation Research Center of Excellence, University of Michigan, Ann Arbor, MI, 48109, USA.
  • Scott PJH; Functional Neuroimaging, Cognitive, and Mobility Laboratory, Department of Radiology, University of Michigan, Ann Arbor, MI, USA.
  • Bohnen NI; Department of Radiology, University of Michigan, Ann Arbor, MI, 48109, USA.
Article en En | MEDLINE | ID: mdl-38958681
ABSTRACT

PURPOSE:

Preliminary data suggest that gait abnormalities in Parkinson disease (PD) may be associated with sympathetic cardiac denervation. No kinematic gait studies were performed to confirm this observation. We aimed to correlate spatiotemporal kinematic gait parameters with cardiac sympathetic denervation as determined by cardiac [11C]HED PET in PD.

METHODS:

Retrospective database analysis of 27 PD patients with cardiac sympathetic denervation. All patients underwent spatiotemporal kinematic gait assessment (medication 'off' state), cardiac [11C]HED and dopaminergic brain [11C]DTBZ PET scans. We employed a hierarchical regression approach to examine associations between the extent of cardiac denervation, dopaminergic nigrostriatal neurodegeneration, and three gait parameters - velocity, step length and cadence.

RESULTS:

More extensive cardiac denervation was associated with slower velocity (estimate -1.034, 95% CI [-1.65, -0.42], p = 0.002), shorter step length (estimate -0.818, 95% CI [-1.43, -0.21], p = 0.011) and lower cadence (estimate -0.752, 95% CI [-1.28, -0.23], p = 0.007) explaining alone 30% (Adjusted-R² 0.297), 20% (Adjusted-R² 0.202) and 23% (Adjusted-R² 0.227) of the variability, respecivetly. These associations remained independent of striatal dopaminergic impairment and confounding factors such as age, Hoehn and Yahr (HY) stages, peripheral neuropathy, cognition, and autonomic symptoms. In contrast, striatal dopaminergic denervation was significantly associated with step length (estimate 0.883, 95% CI [0.29, 1.48], p = 0.005), explaining about 24% of the variability but was dependent of HY stage.

CONCLUSIONS:

More severe cardiac noradrenergic denervation was associated with lower gait velocity, independent of striatal dopaminergic denervation and HY stage, impacting both step length and cadence. These results suggest independent contributions of the peripheral autonomic system degeneration on gait dynsfunction in PD.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos